Dana B. Sparks

Also affiliated with Bayer (United States), Bristol-Myers Squibb (Germany), Ipsen (France), Mirati Therapeutics (United States), Gilead Sciences (United Kingdom), AstraZeneca (France), Janssen (Switzerland), Boehringer Ingelheim (India), Pharmacyclics (United States), Bicycle Therapeutics (United Kingdom), Gilead Sciences (United States), Clovis Oncology (United Kingdom), SWOG Cancer Research Network, Eisai (Japan), Endocyte (United States), Incyte (United States)

MedicineEconomics, Econometrics and FinanceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 1 paper. Top paper: “National impact of the COVID-19 pandemic on clinical trial staff attrition: Results of the SWOG Cancer Research Network Survey of Oncology Research Professionals.”.

National impact of the COVID-19 pandemic on clinical trial staff attrition: Results of the SWOG Cancer Research Network Survey of Oncology Research Professionals.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.11049

N/A

0DataRank · unranked

12 citations

Connie M. Szczepanek, Daniel P. Petrylak, Dana B. Sparks, Catherine M. Tangen, Primo N. Lara +3 more